← Leaderboards
Valeria Cavalcanti Rolla
Vanderbilt University Medical Center
$1,296,157
Attributed
$2,592,314
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $655.7K · FY2016–19$1M$750K$500K$250K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$2,592,314 · 1
By mechanism
R01$2,592,314 · 1
Top collaborators
- Timothy R Sterling4 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Kelly E. Dooley$16,423,496
- David W Haas$38,631,058
- Timothy R Sterling$15,317,436
- Dan M Roden$145,793,078
- Bruno De Bezerril Andrade$7,269,169
Others in their field
Top investigators on “Drug Interactions”
- Sharon A Nachman · Johns Hopkins University$209,857,565
- David Heimbrook · Leidos Biomedical Research, Inc.$173,156,929
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
Research focus
Drug InteractionsDrug ExposureAcetylationAccountingAdherenceAffectAlcoholsAntiretroviral TherapyBaseAdverse EventAdverse ReactionsBurden Of IllnessCessation Of LifeCharacteristicsCohortCo-InfectionConfounding Factors (Epidemiology)Cyp2b6 GeneCyp2e1 GeneDermatologicBody Mass IndexDoseBrazilDrug Kinetics
Grant awards (4)
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis$641,929
R01 · FY2019 · AI
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis$648,910
R01 · FY2018 · AI
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis$645,774
R01 · FY2017 · AI
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis$655,701
R01 · FY2016 · AI